MedTrace Logo

Behavioral Pharmacology of Cannabis and Nicotine

NCT04124432 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2024-04-17

Study results available
· View outcomes & findings →

Summary

This study will evaluate the individual and interactive pharmacokinetic and pharmacodynamic effects of smoked cannabis and nicotine.

Conditions

Interventions

DRUG

Cannabis

Cannabis will be smoked

DRUG

Nicotine

Nicotine will be smoked or vaporized

Sponsors & Collaborators

Principal Investigators

  • Ryan Vandrey · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-15
Primary Completion
2023-07-24
Completion
2023-08-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04124432 on ClinicalTrials.gov